Douglas M. Fambrough, III
2013
In 2013, Douglas M. Fambrough, III earned a total compensation of $1.7M as President and Chief Executive Officer at Dicerna Pharmaceuticals, a 278% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $164,063 |
|---|---|
| Option Awards | $1,151,485 |
| Salary | $375,000 |
| Other | $8,875 |
| Total | $1,699,423 |
Fambrough received $1.2M in option awards, accounting for 68% of the total pay in 2013.
Fambrough also received $164.1K in non-equity incentive plan, $375K in salary and $8.9K in other compensation.
Rankings
In 2013, Douglas M. Fambrough, III's compensation ranked 4,464th out of 12,286 executives tracked by ExecPay. In other words, Fambrough earned more than 63.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,464 out of 12,286 | 64th |
Division Manufacturing | 1,533 out of 4,612 | 67th |
Major group Chemicals And Allied Products | 435 out of 1,462 | 70th |
Industry group Drugs | 300 out of 1,156 | 74th |
Industry Pharmaceutical Preparations | 241 out of 890 | 73rd |
Source: SEC filing on April 30, 2015.
Fambrough's colleagues
We found three more compensation records of executives who worked with Douglas M. Fambrough, III at Dicerna Pharmaceuticals in 2013.